首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Nogo-B (Reticulon-4B) functions as a negative regulator of the apoptotic pathway through the interaction with c-FLIP in colorectal cancer cells
【24h】

Nogo-B (Reticulon-4B) functions as a negative regulator of the apoptotic pathway through the interaction with c-FLIP in colorectal cancer cells

机译:Nogo-B(reticulon-4b)通过与结肠直肠癌细胞的C-翻盖相互作用,用作凋亡途径的负调节剂

获取原文
获取原文并翻译 | 示例
       

摘要

Nogo-B is a member of the Nogo/Reticulon-4 family and has been reported to be an inducer of apoptosis in certain types of cancer cells. However, the role of Nogo-B in human cancer remains less understood. Here, we demonstrated the functions of Nogo-B in colorectal cancer cells. In clinical colorectal cancer specimens, Nogo-B was obviously overexpressed, as determined by immunohistochemistry; and Western blot analysis showed its expression level to be significantly up-regulated. Furthermore, knockdown of Nogo-B in two colorectal cancer cell lines, SW480 and DLD-1, by transfection with si-RNA (siR) resulted in significantly reduced cell viability and a dramatic increase in apoptosis with insistent overexpression of cleaved caspase-8 and cleaved PARP. The transfection with Nogo-B plasmid cancelled that apoptosis induced by siRNogoB in SW480 cells. Besides, combinatory treatment with siR-Nogo-B/staurosporine (STS) or siR-Nogo-B/Fas ligand (FasL) synergistically reduced cell viability and increased the expression of apoptotic signaling proteins in colorectal cancer cells. These results strongly support our contention that Nogo-B most likely played an oncogenic role in colorectal cancer cells, mainly by negatively regulating the extrinsic apoptotic pathway in them. Finally, we revealed that suppression of Nogo-B caused down-regulation of c-FLIP, known as a major anti-apoptotic protein, and activation of caspase-8 in the death receptor pathway. Interaction between Nogo-B and c-FLIP was shown by im-munoprecipitation and immunofluorescence studies.
机译:Nogo-B是Nogo / Tericulon-4系列的成员,并据报道是某些类型的癌细胞中细胞凋亡的诱导剂。然而,Nogo-B在人类癌症中的作用仍然不太了解。在这里,我们证明了Nogo-B在结肠直肠癌细胞中的功能。在临床结肠直肠癌标本中,通过免疫组织化学确定,Nogo-B明显过表达;和Western印迹分析显示其表达水平明显上调。此外,通过用Si-RNA(SIR)转染在两种结肠直肠癌细胞系,SW480和DLD-1中的Nogo-B敲低导致细胞活力显着降低,并且具有裂解的Caspase-8的凋亡的细胞凋亡的显着增加切割PARP。用Nogo-B质粒转染取消了SW480细胞中SIRNOGOB诱导的细胞凋亡。此外,用SiR-Nogo-B / Staurosporine(STS)或SIR-Nogo-B / Fas配体(FasL)的组合治疗协同降低的细胞活力并增加结直肠癌细胞中凋亡信号蛋白的表达。这些结果强烈支持我们的争论,即Nogo-B最有可能在结肠直肠癌细胞中发挥致癌作用,主要是通过对其中的外在凋亡途径进行负面调节。最后,我们揭示了Nogo-B的抑制导致C翻转的调节,称为主要的抗凋亡蛋白,并在死亡受体途径中激活Caspase-8。 IM-Mun Propipitipitipitipitipitipition和免疫荧光研究显示了Nogo-B和C-翻盖之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号